featured
Brentuximab Vedotin in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brentuximab Vedotin in Combination With Chemotherapy for Pediatric Patients With ALK+ALCL: Results of COG Trial ANHL12P1
Blood 2021 Mar 08;[EPub Ahead of Print], EJ Lowe, AF Reilly, MS Lim, TG Gross, L Saguilig, DA Barkauskas, R Wu, S Alexander, CM BollardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.